细胞隔离市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品、细胞类型、来源、技术、按应用、最终用户、地区和竞争细分

全球细胞分离市场价值将于 2022 年达到 40.3 亿美元，并有望实现显着增长，预计到 2028 年复合年增长率 (CAGR) 为 13.04%。细胞分离，也称为细胞分选，是一个过程从细胞群的异质混合物中辨识和分离特定细胞。这些目标细胞根据其细胞类型被分离和分离。细胞分离的常见方法包括磁力激活细胞分离、过滤、离心和流式细胞仪。

细胞分离在诊断疾病、进行细胞研究以及透过分析核糖核酸 (RNA) 表达来开发疗法方面发挥关键作用。它简化了细胞的实验分析，并减少了样本中其他细胞类型的干扰。因此，它在癌症研究、干细胞生物学、免疫学和神经学等领域有着广泛的应用。利用分离细胞的创新技术的一个例子是膜片钳电生理学，它检查带电粒子穿过细胞膜的运动。分离的细胞在细胞培养中也很有用，其中单一细胞繁殖形成细胞集落。

此外，细胞分离具有多种治疗应用。例如，可以分离、培养和移植胰岛细胞来治疗第 1 型糖尿病患者。

市场概况
预测期	2024-2028
2022 年市场规模	40.3亿美元
2028 年市场规模	84.4亿美元
2023-2028 年复合年增长率	13.04%
成长最快的细分市场	癌症研究
最大的市场	北美洲

主要市场驱动因素

慢性病盛行率增加

糖尿病和癌症等慢性疾病的发生率不断上升，导致对细胞疗法的需求增加。此外，细胞分离在各种诊断实验和慢性疾病研究中发挥着至关重要的作用。在药物发现中，细胞分离对于研究细胞行为、疾病反应和药物影响至关重要。细胞分离工具越来越多地应用于药物发现技术中，以开发重组蛋白疗法，用于治疗多种疾病，包括癌症、自体免疫疾病和遗传性疾病。慢性病的全球流行进一步扩大了分离的人体细胞在研究、药物开发和临床试验中的应用。因此，在慢性病发病率不断上升的推动下，对细胞疗法的需求不断增长，导致对细胞分离工具的需求不断增加。

製药和生物技术产业的研究活动迅速增加

细胞分离/细胞分离市场的强劲成长可归因于製药和生物技术产业内研究活动的显着增加。这种激增是由于疾病数量的迅速增加以及发达的基础设施和技术的进步而造成的。这些因素导致了对有效细胞分离和分离技术的需求，这进一步推动了市场的成长。

此外，对实验室自动化不断增长的需求也在促进细胞分离/细胞分离市场的成长中发挥了关键作用。随着实验室寻求简化流程并提高效率，采用自动化解决方案进行细胞分离变得越来越重要。随着越来越多的公司和研究机构认识到实验室自动化在其科学工作中的好处和优势，这反过来又推动了市场的扩张。许多生物技术公司，包括来自不发达国家的公司，正在冒险进入这个市场。製药公司可能会利用细胞分离技术来开发新药物并促进创新。这些公司已经收购了重要的独立单位来支持不断扩大的干细胞研究领域。生物技术和製药公司产业预计将受到细胞分离技术推动的药物和治疗（例如 CAR-T）的进步的推动。目前，美国有 449 家上市生技公司，预计将推动生技和製药公司的市场。

政府加强生物医学研究活动的政策

近年来，世界各国政府为支持和促进生物医学研究活动而实施的措施和政策显着增加。这主要是由于客户对此类研究重要性的认识不断提高，以及人口老化和慢性病盛行率上升。因此，细胞隔离市场经历了快速成长的轨迹。

生物技术领域的大量投资和医疗保健基础设施的不断改善预计将进一步刺激细胞分离市场的扩张。这些投资和进步不仅有助于市场的整体成长，而且促进了细胞分离领域的创新和技术进步。

随着老年人口的增长，对临床试验和研究的需求也增加

与年轻人相比，65 岁及以上的老年族群更容易罹患癌症和神经系统疾病等慢性疾病。值得注意的是，老年人口正在经历快速增长，这进一步放大了解决这些健康问题的重要性。随着 65 岁及以上人口数量的不断增加，阿兹海默症、失智症、癌症和免疫性疾病等疾病的盛行率预计将显着上升。

因此，针对这些情况的矫正治疗的需求将会不断增加。预计这种需求激增也将扩展到细胞分离产品领域，该产品在包括临床试验在内的各种研究工作中发挥着至关重要的作用。因此，在这些因素的推动下，全球细胞分离技术市场预计将大幅成长。

主要市场挑战

缺乏技术熟练的个人

该领域技术熟练的工人短缺，加上人们越来越担心细胞分离程序存在严格的规则和合规性，预计将限制整体市场的扩张。此外，与细胞分离技术植入治疗相关的高成本可能对未来几年市场的成长构成重大威胁。这些因素突显出需要采取策略措施和创新解决方案来克服这些挑战并促进可持续的市场成长。

从实验室诊断转向家庭测试

在客户意识增强的推动下，从实验室诊断转向家庭测试，导致併发症发生的可能性降低，技术也取得了显着进展。因此，细胞分离/细胞分离市场的成长预计将放缓。此外，与服务合约和原材料相关的高成本可能会阻碍市场成长。这些因素共同导致了细胞隔离市场面临的挑战，强调需要策略解决方案来解决这些问题并确保产业的持续成长。

主要市场趋势

技术进步

预计细胞分离技术市场在未来几年将经历显着的成长机会。这可以归因于基于细胞的技术的快速进步，例如更高的纯度产量和更少的细胞分离时间。此外，政府为改进细胞技术和细胞分离技术的成本效益而采取的措施的增加预计将有助于市场成长。此外，发展中国家发达的医疗基础设施为细胞分离技术的采用和实施提供了有利的环境。所有这些因素结合在一起，使得细胞分离技术市场在可预见的未来将大幅扩张。

产品创新

产品供应的进步推动了全球细胞分离市场的成长。该市场的产品创新主要是由各种慢性和传染病的细胞研究中对自动化工具不断增长的需求所推动的。 BD 和 QIAGEN 等市场主要参与者致力于持续改进产品。例如，2019 年3 月，BD 推出了BD FACSDuet 自动流式细胞仪系统，这是一种全自动样品製备仪器，可在BD FACSLyric 临床流程上运行检测时最大限度地减少错误并减少手动用户交互的需要，从而提高临床实验室的效率细胞仪。其他供应商，如 Bio-Rad，则专注于流式细胞仪试剂的开发。 2020 年 11 月，Bio-Rad Laboratories, Inc. 推出了 StarBright Blue 700、StarBright Violet 440 和 StarBright Violet 610 染料，为流式细胞仪提供最大亮度和更高的分辨率。因此，成熟市场参与者不断改进产品推动了市场成长并有助于增加这些产品的销售量。

细分市场洞察

细胞类型见解

根据细胞类型，市场分为人类细胞和动物细胞。 2022年，人类细胞类别在收入份额方面成为领先者。这可以归因于人们对癌症和人类研究的日益重视，以及分离的人类细胞在生物製药开发、临床试验和研究中的广泛应用。此外，工业化国家对个人化医疗有吸引力的支付政策进一步促进了对人体细胞分离的需求。预计动物细胞领域在预测期内也将获利成长。新药的开发引起了政府机构、商业部门和医疗机构的高度关注，从而推动了该领域的成长。动物细胞在新药的发现和开发中发挥着至关重要的作用，能够评估毒性、药物动力学和有效性。

技术见解

根据技术领域，市场分为基于离心的细胞分离、基于表面标记的细胞分离和基于过滤的细胞分离。基于离心的细胞分离细分市场在 2022 年占据最大的收入份额，一直是细胞分离市场的主导力量。该技术被学术机构、研究中心和生物技术/生物製药公司广泛使用。离心在细胞分离中起着至关重要的作用，常用的差速离心和密度梯度离心。密度梯度离心利用分子量进行颗粒分离，而差速离心则利用裂解物破坏细胞膜。

展望未来，表面标记和过滤领域预计将显着成长。这一市场扩张主要是由产品开发和企业对製造基础设施投资的增加所推动的。製造商在生产和研究过程中利用创新的表面标记和过滤系统来提高最终产品的品质。

区域洞察

在慢性病盛行率不断上升、个人化医疗需求不断增长以及政府对细胞研究和开发的资助的推动下，北美市场预计将在未来几年引领全球细胞分离产业。凭藉其先进的医疗保健系统、强大的研发部门以及对生物技术研究的不断增加的投资，北美地区预计将出现最显着的收入成长。

由于医疗成本不断上升、患者群体庞大以及对尖端细胞分离方法的兴趣日益浓厚等因素，预计亚太地区的细胞分离市场将快速扩张。该地区拥有多个新兴国家，包括中国和印度，这些国家的慢性病发病率正在上升。此外，技术人员的可及性和可承受的生产成本预计将吸引细胞分离产业的众多主要参与者来到该地区。

在政府生命科学研究和开发支出增加以及慢性疾病流行等因素的推动下，欧洲市场预计将呈现温和成长。 Thermo Fisher Scientific、STEMCELL Technologies 和 Merck KGaA 等细胞分离市场的主要参与者都是该地区的知名公司。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场区隔

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要产业伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球细胞隔离市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品（消耗品和仪器）
  • 依细胞类型（人类细胞和动物细胞）
  • 依来源分类（骨髓、脐带血/胚胎干细胞、脂肪组织）
  • 依技术分类（基于离心的细胞分离、基于表面标记的细胞分离、基于过滤的细胞分离）
  • 按应用（生物分子分离、癌症研究、干细胞研究、体外诊断、其他）
  • 按最终用户（生物技术和生物製药公司、研究实验室和研究所、医院和诊断实验室、细胞库）
  • 按地区
  • 按公司划分 (2022)
• 市场地图

第 6 章：北美细胞隔离市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按细胞类型
  • 按来源
  • 依技术
  • 按应用
  • 按最终用户
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲细胞隔离市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按细胞类型
  • 按来源
  • 依技术
  • 按应用
  • 按最终用户
  • 按国家/地区
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太地区细胞隔离市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按细胞类型
  • 按来源
  • 依技术
  • 按应用
  • 按最终用户
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲细胞隔离市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按细胞类型
  • 按来源
  • 依技术
  • 按应用
  • 按最终用户
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲细胞隔离市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按细胞类型
  • 按来源
  • 依技术
  • 按应用
  • 按最终用户
  • 按国家/地区
• MEA：国家分析
  • 南非细胞分离
  • 沙乌地阿拉伯细胞分离
  • 阿联酋细胞分离

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球细胞隔离市场：SWOT 分析

第 14 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第15章：竞争格局

• 商业概览
• 服务内容
• 最近的发展
• 主要人员
• SWOT分析
  • Becton, Dickinson & Company
  • Merck KGaA (Millipore Sigma)
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Terumo Corporation
  • PluriSelect Life Science UG & Co. KG
  • Danaher Corporation (Cytiva)
  • STEMCELL Technologies Inc.
  • Corning Inc.
  • Akadeum Life Sciences Inc.

第 16 章：策略建议

第 17 章：关于我们与免责声明

The Global Cell Isolation Market reached a value of USD 4.03 Billion in 2022 and is poised for remarkable growth, with an expected Compound Annual Growth Rate (CAGR) of 13.04% through 2028. Cell isolation, also known as cell sorting, is the process of identifying and separating specific cells from a heterogeneous mixture of cell populations. These targeted cells are isolated and separated based on their cell type. Common methods for cell isolation include magnet-activated cell isolation, filtration, centrifugation, and flow cytometry.

Cell isolation plays a pivotal role in diagnosing diseases, conducting cellular research, and developing therapies by analyzing ribonucleic acid (RNA) expressions. It simplifies the experimental analysis of cells and reduces interference from other cell types within the sample. Consequently, it finds extensive applications in fields such as cancer research, stem cell biology, immunology, and neurology. An example of an innovative technique that utilizes isolated cells is patch-clamp electrophysiology, which examines the movement of charged particles across the cell membrane. Isolated cells are also instrumental in cell culture, where a single cell multiplies to form a colony of cells.

Moreover, cell isolation has various therapeutic applications. For instance, pancreatic islet cells can be isolated, cultured, and transplanted to treat patients with Type 1 Diabetes.

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 4.03 Billion
Market Size 2028	USD 8.44 Billion
CAGR 2023-2028	13.04%
Fastest Growing Segment	Cancer Research
Largest Market	North America

Key Market Drivers

Increasing Prevalence of Chronic Diseases

The growing incidence of chronic diseases, such as diabetes and cancer, has led to an increased demand for cell-based therapies. Additionally, cell isolation plays a crucial role in various diagnostic experiments and research on chronic diseases. In drug discovery, cell isolation is essential for studying cellular behavior, disease response, and drug impact. Cell isolation tools are increasingly utilized in drug discovery techniques to develop recombinant protein therapeutics for treating a wide range of diseases, including cancer, autoimmune disorders, and genetic conditions. The global prevalence of chronic diseases has further amplified the applications of isolated human cells in research, drug development, and clinical trials. Therefore, the rising demand for cell-based therapies, driven by the growing incidence of chronic diseases, has resulted in an increased need for cell isolation tools.

The growth of chronic diseases, such as diabetes, obesity, arthritis, heart disorders, and cancer, is influenced by factors like increased sedentary lifestyle, global population aging, and higher rates of cigarette smoking and alcohol consumption. According to Imperial College London, chronic illnesses were projected to account for over 70% of global fatalities in 2020, with more than 41 million deaths annually. Approximately 17 million of these deaths are considered premature, occurring at a younger age than expected.

Consequently, the demand for cellular therapies to address chronic diseases is escalating alongside the burden of these conditions. This has led to increased focus and funding in research to develop effective remedies. As a result, the global market for cell isolation technologies is being driven by the growing activities in cellular research.

Rapid Increase in The Research Activities In The Pharmaceutical And Biotechnological Industries

The robust growth of the Cell Isolation/Cell isolation Market can be attributed to the significant increase in research activities within the pharmaceutical and biotechnological industries. This surge is in response to the rapid rise in the number of diseases, as well as the presence of well-developed infrastructures and advancements in technology. These factors contribute to the need for effective cell isolation and separation techniques, which further drives the market growth.

Moreover, the growing demand for laboratory automation has also played a pivotal role in enhancing the growth of the Cell Isolation/Cell isolation Market. As laboratories seek to streamline their processes and improve efficiency, the adoption of automated solutions for cell isolation and separation becomes increasingly important. This, in turn, fuels the expansion of the market, as more companies and research institutions recognize the benefits and advantages of laboratory automation in their scientific endeavors. Numerous biotechnology companies, including those from underdeveloped nations, are venturing into the market. Pharmaceutical corporations are likely to utilize cell isolation techniques to develop new medications and foster innovation. These companies have acquired significant independent units to support the expanding stem cell research field. The biotechnology and pharmaceutical firms' sector is expected to be propelled by the advancements in medications and treatments, such as CAR-T, facilitated by cell isolation technologies. Currently, there are 449 public biotech companies operating in the U.S., which is anticipated to drive the market for biotechnology and pharmaceutical companies.

Government's Policies to Enhance Biomedical Research Activities

In recent years, there has been a remarkable surge in initiatives and policies implemented by governments worldwide to support and promote biomedical research activities. This is primarily driven by the increasing awareness among customers about the significance of such research, as well as the growing number of aging population and the rising prevalence of chronic diseases. Consequently, the Cell Isolation Market has experienced a rapid growth trajectory.

Substantial investments in the biotechnology sector and continuous improvements in the healthcare infrastructure are expected to further stimulate the expansion of the Cell Isolation Market. These investments and advancements not only contribute to the overall growth of the market but also foster innovation and technological advancements in the field of cell isolation and separation.

Demand For Clinical Trials and Research Is Increasing As The Geriatric Population Grows

The senior population, comprising individuals aged 65 and over, is more prone to chronic illnesses such as cancer and neurological disorders when compared to the younger population. Notably, the geriatric population is experiencing rapid growth, which further magnifies the significance of addressing these health concerns. With the increasing number of individuals aged 65 and over, the prevalence of conditions like Alzheimer's, dementia, cancer, and immunological illnesses is expected to rise significantly.

Consequently, there will be an escalating demand for corrective treatments to cater to these conditions. This surge in demand is also projected to extend to the field of cell isolation products, which play a crucial role in various research endeavors, including clinical trials. As a result, the global market for cell isolation technologies is anticipated to witness substantial growth, driven by these factors.

Key Market Challenges

Lack of Technically Skilled Individuals

The shortage of technically competent workers in the field, coupled with the increasing concerns about the existence of tight rules and compliances for cell separation procedures, are projected to restrain the overall market expansion. Moreover, the high cost associated with cell separation technology implant treatments can potentially pose a significant threat to the growth of the market in the coming years. These factors highlight the need for strategic measures and innovative solutions to overcome these challenges and foster sustainable market growth.

Shift From Lab-Based Diagnosis to Home-Based Testing

The shift from lab-based diagnosis to home-based testing, driven by increased customer awareness, has led to a decrease in the chances of complications and significant advancements in technology. As a result, the growth of the Cell Isolation/Cell Separation Market is anticipated to be reduced. Additionally, the market growth may be hampered by the high costs associated with service contracts and raw materials. These factors collectively contribute to the challenges faced by the Cell Isolation Market, emphasizing the need for strategic solutions to address these concerns and ensure sustained growth in the industry.

Key Market Trends

Technological Advancement

It is anticipated that the cell separation technology market will experience significant growth opportunities in the coming years. This can be attributed to the rapid technological advancements in cell-based technology, such as higher purity yield and reduced cell isolation time. Additionally, the rise in government initiatives to improve cell-based technology and the cost-effectiveness of cell separation techniques are expected to contribute to market growth. Furthermore, the well-developed healthcare infrastructure in developing countries provides a favorable environment for the adoption and implementation of cell separation technologies. All these factors combined make the cell separation technology market poised for substantial expansion in the foreseeable future.

Product Innovations

The growth of the global cell isolation market is being fueled by advancements in the product offerings. Product innovations in this market are primarily driven by the increasing demand for automated tools in cell-based research for various chronic and infectious diseases. Key players in the market, such as BD and QIAGEN, are dedicated to continuous product improvement. For instance, in March 2019, BD introduced the BD FACSDuet automated flow cytometry system, a fully automated sample preparation instrument that enhances the efficiency of clinical laboratories by minimizing errors and reducing the need for manual user interactions when running assays on the BD FACSLyric clinical flow cytometer. Other vendors, like Bio-Rad, are focused on the development of reagents for flow cytometry. In November 2020, Bio-Rad Laboratories, Inc. launched StarBright Blue 700, StarBright Violet 440, and StarBright Violet 610 dyes, which provide maximum brightness and improved resolution for flow cytometry. Hence, the continuous product advancements by established market players drive market growth and contribute to increased sales of these products.

Segmental Insights

Cell Type Insights

Based on the cell type, the market is segmented into human cells and animal cells. In 2022, the human cell category emerged as the leader in terms of revenue share. This can be attributed to the growing emphasis on cancer and human research, as well as the wide range of applications of isolated human cells in biopharmaceutical development, clinical trials, and research. Moreover, the attractive payment policies for personalized medicine in industrialized countries further contribute to the demand for human cell isolation. It is projected that the animal cells segment will also witness profitable growth during the forecast period. The development of novel drugs has garnered significant attention from government bodies, the commercial sector, and healthcare organizations, thereby driving the growth of this segment. Animal cells play a crucial role in the discovery and development of new drugs, enabling the assessment of toxicity, pharmacokinetics, and effectiveness.

Technique Insights

Based on the technique segment, the market is segmented into centrifugation-based cell isolation, surface marker-based cell isolation, and filtration-based cell isolation. The centrifugation-based cell isolation segment, accounted for the largest revenue share in 2022, has been a dominant force in the cell separation market. This technique is widely utilized by academic institutions, research centers, and biotechnology/biopharmaceutical companies. Centrifugation plays a crucial role in cell isolation, with both differential centrifugation and density gradient centrifugation commonly employed. Density gradient centrifugation leverages molecular weights for particle separation, while differential centrifugation employs lysates to disrupt cell membranes.

Looking ahead, significant growth is expected in both the surface marking and filtration segments. This market expansion is primarily driven by product development and increased corporate investments in manufacturing infrastructure. Manufacturers utilize innovative surface markers and filtration systems in their production and research processes to enhance the quality of the final product.

Regional Insights

The North American market is poised to lead the global cell isolation industry in the coming years, driven by the increasing prevalence of chronic diseases, growing demand for personalized medicine, and government funding for cell-based research and development. With its advanced healthcare system, robust research and development sector, and increasing investment in biotechnology research, North America is expected to witness the most significant revenue growth.

Asia Pacific is anticipated to experience rapid expansion in the cell isolation market due to factors such as escalating healthcare costs, a large patient base, and growing interest in cutting-edge cell separation methods. The region boasts several emerging nations, including China and India, where the incidence of chronic diseases is on the rise. Additionally, the accessibility to skilled personnel and affordable production costs is expected to attract numerous major players in the cell isolation industry to the region.

The European market is projected to exhibit moderate growth, driven by factors such as increased government spending on life sciences research and development and the prevalence of chronic disorders. Key players in the cell isolation market, such as Thermo Fisher Scientific, STEMCELL Technologies, and Merck KGaA, are among the notable companies based in the region.

Key Market Players

• Becton, Dickinson & Company

• Merck KGaA (Millipore Sigma)

• Thermo Fisher Scientific Inc.

• Bio-Rad Laboratories Inc.

• Terumo Corporation

• PluriSelect Life Science UG & Co. KG

• Danaher Corporation (Cytiva)

• STEMCELL Technologies Inc.

• Corning Inc.

• Akadeum Life Sciences Inc.

Report Scope:

In this report, the Global Cell Isolation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Isolation Market, By Product:

• Consumables
• Instruments

Cell Isolation Market, By Cell Type:

• Human Cells
• Animal Cells

Cell Isolation Market, By Source:

• Bone Marrow
• Cord Blood/Embryonic Stem Cells
• Adipose Tissue

Cell Isolation Market, By Technique:

• Centrifugation-Based Cell Isolation
• Surface Marker-Based Cell Isolation
• Filtration-Based Cell

Cell Isolation Market, By Application:

• Biomolecule Isolation
• Cancer Research
• Stem Cell Research
• In Vitro Diagnostic
• Others

Cell Isolation Market, By End User:

• Biotechnology and Biopharmaceutical Companies
• Research Laboratories and Institutes
• Hospitals and Diagnostic Laboratories
• Cell Banks

Cell Isolation Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Cell Isolation Market.

Available Customizations:

• Global Cell Isolation market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Isolation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Consumables and Instruments)
  • 5.2.2. By Cell Type (Human Cells and Animal Cells)
  • 5.2.3. By Source (Bone Marrow, Cord Blood/Embryonic Stem Cells, Adipose Tissue)
  • 5.2.4. By Technique (Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, Filtration-Based Cell Isolation)
  • 5.2.5. By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, In Vitro Diagnostics, Others)
  • 5.2.6. By End User (Biotechnology and Biopharmaceutical Companies, Research Laboratories and Institutes, Hospitals and Diagnostic Laboratories, Cell Banks)
  • 5.2.7. By Region
  • 5.2.8. By Company (2022)
• 5.3. Market Map

6. North America Cell Isolation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Cell Type
  • 6.2.3. By Source
  • 6.2.4. By Technique
  • 6.2.5. By Application
  • 6.2.6. By End User
  • 6.2.7. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cell Isolation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Cell Type
      • 6.3.1.2.3. By Source
      • 6.3.1.2.4. By Technique
      • 6.3.1.2.5. By Application
      • 6.3.1.2.6. By End User
  • 6.3.2. Canada Cell Isolation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Cell Type
      • 6.3.2.2.3. By Source
      • 6.3.2.2.4. By Technique
      • 6.3.2.2.5. By Application
      • 6.3.2.2.6. By End User
  • 6.3.3. Mexico Cell Isolation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Cell Type
      • 6.3.3.2.3. By Source
      • 6.3.3.2.4. By Technique
      • 6.3.3.2.5. By Application
      • 6.3.3.2.6. By End User

7. Europe Cell Isolation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Cell Type
  • 7.2.3. By Source
  • 7.2.4. By Technique
  • 7.2.5. By Application
  • 7.2.6. By End User
  • 7.2.7. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cell Isolation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Cell Type
      • 7.3.1.2.3. By Source
      • 7.3.1.2.4. By Technique
      • 7.3.1.2.5. By Application
      • 7.3.1.2.6. By End User
      • 7.3.1.2.7.
  • 7.3.2. United Kingdom Cell Isolation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Cell Type
      • 7.3.2.2.3. By Source
      • 7.3.2.2.4. By Technique
      • 7.3.2.2.5. By Application
      • 7.3.2.2.6. By End User
  • 7.3.3. Italy Cell Isolation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Cell Type
      • 7.3.3.2.3. By Source
      • 7.3.3.2.4. By Technique
      • 7.3.3.2.5. By Application
      • 7.3.3.2.6. By End User
  • 7.3.4. France Cell Isolation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Cell Type
      • 7.3.4.2.3. By Source
      • 7.3.4.2.4. By Technique
      • 7.3.4.2.5. By Application
      • 7.3.4.2.6. By End User
  • 7.3.5. Spain Cell Isolation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Cell Type
      • 7.3.5.2.3. By Source
      • 7.3.5.2.4. By Technique
      • 7.3.5.2.5. By Application
      • 7.3.5.2.6. By End User

8. Asia-Pacific Cell Isolation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Cell Type
  • 8.2.3. By Source
  • 8.2.4. By Technique
  • 8.2.5. By Application
  • 8.2.6. By End User
  • 8.2.7. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Cell Isolation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Cell Type
      • 8.3.1.2.3. By Source
      • 8.3.1.2.4. By Technique
      • 8.3.1.2.5. By Application
      • 8.3.1.2.6. By End User
  • 8.3.2. India Cell Isolation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Cell Type
      • 8.3.2.2.3. By Source
      • 8.3.2.2.4. By Technique
      • 8.3.2.2.5. By Application
      • 8.3.2.2.6. By End User
  • 8.3.3. Japan Cell Isolation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Cell Type
      • 8.3.3.2.3. By Source
      • 8.3.3.2.4. By Technique
      • 8.3.3.2.5. By Application
      • 8.3.3.2.6. By End User
  • 8.3.4. South Korea Cell Isolation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Cell Type
      • 8.3.4.2.3. By Source
      • 8.3.4.2.4. By Technique
      • 8.3.4.2.5. By Application
      • 8.3.4.2.6. By End User
  • 8.3.5. Australia Cell Isolation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Cell Type
      • 8.3.5.2.3. By Source
      • 8.3.5.2.4. By Technique
      • 8.3.5.2.5. By Application
      • 8.3.5.2.6. By End User

9. South America Cell Isolation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Cell Type
  • 9.2.3. By Source
  • 9.2.4. By Technique
  • 9.2.5. By Application
  • 9.2.6. By End User
  • 9.2.7. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cell Isolation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Cell Type
      • 9.3.1.2.3. By Source
      • 9.3.1.2.4. By Technique
      • 9.3.1.2.5. By Application
      • 9.3.1.2.6. By End User
  • 9.3.2. Argentina Cell Isolation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Cell Type
      • 9.3.2.2.3. By Source
      • 9.3.2.2.4. By Technique
      • 9.3.2.2.5. By Application
      • 9.3.2.2.6. By End User
  • 9.3.3. Colombia Cell Isolation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Cell Type
      • 9.3.3.2.3. By Source
      • 9.3.3.2.4. By Technique
      • 9.3.3.2.5. By Application
      • 9.3.3.2.6. By End User

10. Middle East and Africa Cell Isolation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Cell Type
  • 10.2.3. By Source
  • 10.2.4. By Technique
  • 10.2.5. By Application
  • 10.2.6. By End User
  • 10.2.7. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cell Isolation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Cell Type
      • 10.3.1.2.3. By Source
      • 10.3.1.2.4. By Technique
      • 10.3.1.2.5. By Application
      • 10.3.1.2.6. By End User
  • 10.3.2. Saudi Arabia Cell Isolation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Cell Type
      • 10.3.2.2.3. By Source
      • 10.3.2.2.4. By Technique
      • 10.3.2.2.5. By Application
      • 10.3.2.2.6. By End User
  • 10.3.3. UAE Cell Isolation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Cell Type
      • 10.3.3.2.3. By Source
      • 10.3.3.2.4. By Technique
      • 10.3.3.2.5. By Application
      • 10.3.3.2.6. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Cell Isolation Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Service Offerings
• 15.3. Recent Developments
• 15.4. Key Personnel
• 15.5. SWOT Analysis
  • 15.5.1. Becton, Dickinson & Company
  • 15.5.2. Merck KGaA (Millipore Sigma)
  • 15.5.3. Thermo Fisher Scientific Inc.
  • 15.5.4. Bio-Rad Laboratories Inc.
  • 15.5.5. Terumo Corporation
  • 15.5.6. PluriSelect Life Science UG & Co. KG
  • 15.5.7. Danaher Corporation (Cytiva)
  • 15.5.8. STEMCELL Technologies Inc.
  • 15.5.9. Corning Inc.
  • 15.5.10. Akadeum Life Sciences Inc.

16. Strategic Recommendations

17. About Us & Disclaimer